NEW DELHI, Juun 22 (Xinhua) — Ụlọ ọrụ mmepụta ọgwụ mgbochi Bharat Biotech nke India, Covaxin, egosila na ọ dị irè pasent 77.8 na nnwale nkebi nke atọ, dịka ọtụtụ ndị mgbasa ozi mpaghara kọrọ na Tuzdee.
"Dịka data sitere na nnwale nkebi nke atọ emere na ndị sonyere 25,800 n'ofe India si kwuo, Covaxin nke Bharat Biotech dị irè pasent 77.8 n'ichebe megide COVID-19," ka otu akụkọ kwuru.
Ọnụọgụ arụmọrụ pụtara na Tuzdee mgbe kọmitii ọkachamara n'ihe gbasara ọgwụ (SEC) nke onye na-ahụ maka njikwa ọgwụ ọjọọ (DCGI) zukọrọ ma kparịta maka nsonaazụ ya.
Ụlọ ọrụ ọgwụ ahụ enyela DCGI data nnwale nkebi nke atọ maka ọgwụ mgbochi ahụ n'izu ụka a.
Akụkọ kwuru na a na-atụ anya na ụlọ ọrụ ahụ ga-enwe nzukọ "tupu nnyefe" na ndị ọchịchị nke Òtù Ahụ Ike Ụwa na Wenezde, iji kparịta ntuziaka maka nnyefe ikpeazụ nke data na akwụkwọ achọrọ.
India malitere ịgba ọgwụ mgbochi COVID-19 n'ọtụtụ ebe na Jenụwarị 16 site n'inye ọgwụ mgbochi abụọ e mere na India, ya bụ Covishield na Covaxin.
Ụlọ ọrụ Serum Institute of India (SII) na-emepụta Covishield nke Mahadum AstraZeneca-Oxford, ebe Bharat Biotech na Indian Council of Medical Research (ICMR) jikọrọ aka na imepụta Covaxin.
E mekwara ọgwụ mgbochi Sputnik V nke e mere na mba ahụ na Rọshịa.
Oge ozi: Juun-25-2021